Hamilton Lane Advisors LLC Kala Pharmaceuticals, Inc. Transaction History

Hamilton Lane Advisors LLC

  • $122 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 31, 2020
SELL
$3.36 - $4.81 $117,267 - $167,873
-34,901 Closed
0 $0
Q1 2019

Apr 22, 2019
SELL
$5.19 - $8.97 $148,428 - $256,533
-28,599 Reduced 45.04%
34,901 $289,000
Q3 2018

Oct 16, 2018
BUY
$9.54 - $13.87 $605,790 - $880,745
63,500 New
63,500 $1,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Kala Pharmaceuticals, Inc.

KALA Quotes by TradingView
  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $9.97M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Hamilton Lane Advisors LLC Portfolio

Follow Hamilton Lane Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hamilton Lane Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hamilton Lane Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email